MG

Mahumadhusain Gulamhusain Bhatt

Active Director Designated Partner DIN 09191415
DIN 09191415 First appointment Jun 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahumadhusain Gulamhusain Bhatt

Data last updated:

Mahumadhusain Gulamhusain Bhatt is a Designated Partner at Azurite Pharmaceuticals Llp (since 2021). The company operates in Chemicals.

DIN 09191415
Primary Designation Designated Partner
Industry Chemicals
First Appointment 02 Jun 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Jun 20212021Active

Board colleagues of Mahumadhusain Gulamhusain Bhatt

NameDINCompanyDesignation
Amitkumar Rajkumar Bhavsar09191414Azurite Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Azurite Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Mahumadhusain Gulamhusain Bhatt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahumadhusain Gulamhusain Bhatt

Mahumadhusain Gulamhusain Bhatt currently holds 1 directorship: Azurite Pharmaceuticals Llp (Designated Partner, since 02 Jun 2021).

Mahumadhusain Gulamhusain Bhatt was first appointed on 02 Jun 2021 as Designated Partner at Azurite Pharmaceuticals Llp.

The current boards of Mahumadhusain Gulamhusain Bhatt's companies include Amitkumar Rajkumar Bhavsar (Azurite Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available